Results, reports & presentations

Completion of Adaptas Solutions (“Adaptas”) acquisition

Proposed acquisition of Life Sciences manufacturer Adaptas Solutions for $271m

Trading update - Q3 2021

Capital Markets Presentation - Accelerating Business Performance Event 2

Half-year Results 2021

Capital Markets Presentation - Accelerating Business Performance Event 1

Trading update - Q1 2021

Annual Report 2020

Full-year Results 2020

Trading update - Q3 2020